The North America Sciatica Treatment Market would witness market growth of 2.4% CAGR during the forecast period (2022-2028).
Sciatica pain radiates from the lumbar region of the body (lower back) to the back of the thigh. However, it might extend below the knee as well. The biggest nerve in the human body is the sciatic nerve. The sciatic nerve originates from the lumbar spinal cords nerve roots in the lower back region and extends across the buttock region, directing nerve terminals to the lower limb. A lumbar disc herniation is a common cause of sciatica because it presses directly on the nerve. Sciatica symptoms may be brought on by any factor that inflames or irritates the sciatic nerve.
Radiculopathy is a word used to describe abnormalities in the intervertebral disc caused by nerve irritation. Other causes of sciatica pain, besides a stretched nerve from a disc, include injury, internal bleeding, infections in or around the lumbar spine, muscle, tumors, and nerve irritation from nearby bone. The inflammation of the sciatic nerve may sometimes produce sciatica pain during pregnancy. Several risk factors accompany the discomfort in the sciatic nerve. They include lumbar spine trauma, slipped discs, lumbar disc disease, and degenerative arthritis.
The number of Americans 65 and over increased from 40.3 million in the 2010 Census to 54.1 million in the population estimates as of July 1, 2019, according to the US Census Bureau. Those who are older are more susceptible to illnesses like sciatica. The North American region is anticipated to occupy a significant share of the sciatica market over the forecast period. The United States is one of the most affected countries in the world due to the relatively high numbers of patients struggling with sciatica and higher in the North American geographical area as the patient population is rising compared to other countries.
The US market dominated the North America Sciatica Treatment Market by Country in 2021 and would continue to be a dominant market till 2028; thereby, achieving a market value of $215,115.4 Thousands by 2028. The Canada market is poised to grow at a CAGR of 4.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 3.8% during (2022 - 2028).
Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Sciatica Treatment Market is Predict to reach $810.4 Million by 2028, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)
By Type
By Distribution Channel
By Drug Class
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 